FUJIFILM Announces Start in USA of Clinical Phase II Trial of Antiviral Drug AVIGAN for COVID-19 Patients

Fujifilm has just issued a press release, where they officially announce that their anti-influenza virus drugs “Avigan ® Tablets” has started a clinical phase II study in patients new coronavirus infection in the United States.

The purpose of this study is to confirm the therapeutic efficacy and safety of Avigan.

The study is scheduled to be conducted at three facilities: Brigham and Women’s Hospital, Massachusetts General Hospital, and Massachusetts State University Medical School.

In case you are unaware of the different phases, down below is a table taken from wikipedia.

In Japan, they are at Phase III of the tests already, as we reported here.

Press Release

** CLICK HERE to Read the Rest of the Article **

Fujifilm Drug Avigan (Favipiravir) For COVID-19 (Coronavirus) Treatment Tested Worldwide (USA included) and Offered for Free to 20 Countries

Last month we reported how Zhang Xinmin, director of the science ministry’s China National Center for Biotechnology Development, said that the Fujifilm produced drug Avigan “has a high degree of safety and is clearly effective in treatment” and how a Japanese health ministry source suggested the drug was not as effective in people with more severe symptom.

A few days later, Fujifilm published another official statement, where they announce the start of phase III clinical trial of “Avigan” on COVID-19 Coronavirus and the commitment to increase production.

Avigan is currently tested all over the world, including here in Italy, where I live. But also in USA and many other countries.

Moreover, Japan plans to provide the anti-flu drug Avigan for free to 20 countries hoping to use it to treat coronavirus patients, Foreign Minister Toshimitsu Motegi said Tuesday.

As a consequence, Fujifilm ramped up production of flu drug Avigan as possible COVID-19 treatment.

Fujifilm or not, let’s hope some cure comes up soon, or this unreal situation will keep up for a long time.

Our Owners Groups

Our Facebook Pages

via japantimes via fiercepharma via nypost

Fujifilm’s New Coronavirus Test can Produce Results in 2 Hours

Fujifilm announced that they developed a new fast test for Coronavirus. The New York Times writes:

The SARS-CoV-2 RT-qPCR Detection kit will be able to deliver results for the virus that causes COVID-19 faster than existing polymerase chain reaction (PCR) tests, which presently take four to six hours, the company said.

Fujifilm said the new COVID-19 test will be released on April 15 in their press release (machine translated PDF)

I live here in Italy, and here there is a lot of talk about the urgent need for a fast, simple and affordable test to diagnose COVID-19. Many companies are working on it and I am happy to see Fujifilm is on it, too.

  • read here – Fujifilm Manager Explains Impact and Challenges of Covid-19
  • read here – FUJIFILM Starts Phase III Clinical Trial of Antiviral drug “Avigan” on COVID-19 and Commits to Increasing Production
  • read here – Fujifilm Releases Information of Avigan Tablet in Relation to Covid-19 Coronavirus
  • read here – China Says FUJIFILM Drug Avigan Works Against Coronavirus COVID-19 and Shares Jump up 15%

FujiRumors is on Patreon, Facebook, Instagram, RSS-feed, Youtube, Flipboard and Twitter

Our Owners Groups

Our Facebook Pages

via the New York Times